The pace is picking up for CAR=T approvals. Yescarta will be a little less than 400,000$ for large B lymphoma this black Friday.
"But some analysts think these treatments are a steal at these prices. After all, they include the cost of travel to treatment centers, genetically modifying patient cells, and any drugs needed along the way. "
F.D.A. Approves Second Gene-Altering Treatment for Cancer
"But some analysts think these treatments are a steal at these prices. After all, they include the cost of travel to treatment centers, genetically modifying patient cells, and any drugs needed along the way. "
F.D.A. Approves Second Gene-Altering Treatment for Cancer
Last edited:
